These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 590471)

  • 1. Production of porcine antibodies with high specificity to [8-D-arginine] deamino-vasopressin (dDAVP).
    Slaininová J; Barth T; Franĕk F
    Experientia; 1977 Dec; 33(12):1661-2. PubMed ID: 590471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.
    Lundin S; Melin P; Vilhardt H
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):179-83. PubMed ID: 3969814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug information. Therapeutic main group: antidiuretics. Preparation DDAVP (deamino arginine vasopressin); Minurin, Lypressinum; Insipid retard; Vasopressin].
    Lumholtz IB
    Sygeplejersken; 1977 Aug; 77(30):21. PubMed ID: 242371
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypersensitivity against vasopressin and the synthetic vasopressin-analog DDAVP].
    Flachsbarth F; Wilhelms E
    MMW Munch Med Wochenschr; 1982 May; 124(19):485-6. PubMed ID: 6810116
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 1-deamino-5-D-arginine vasopressin (DDAVP) on plasma cortisol (hydrocortisone).
    Rado JP; Juhos E
    J Clin Pharmacol; 1976 Jul; 16(7):333-7. PubMed ID: 985828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DI patient refractory to vasopressin and dDAVP: absence of antibodies to AVP and dDAVP and inactivating factor in blood serum.
    Slaninová J; Skopková J; Barth T; Lichardus B; Földes O
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):84-6. PubMed ID: 570558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of central diabetes insipidus with a new synthetic preparation: DDAVP (1-deamino-8-D arginine vasopressin). Preliminary experience in 5 cases].
    Bernasconi S; Vanelli M; Giovannelli G
    Minerva Pediatr; 1975 Feb; 27(5):321-6. PubMed ID: 775282
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
    Radó JP; Borbély L
    Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desamino arginine vasopressin (DDAVP) as a diagnostic agent.
    Somerfield SD; Hocken AG
    N Z Med J; 1977 Nov; 86(600):472-3. PubMed ID: 343010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of a new synthetic vasopressin derivative (DDAVP) in man].
    Radó J; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Orv Hetil; 1976 Mar; 117(13):775-8. PubMed ID: 768869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of diabetes insipidus with DDAVP, a synthetic analog of vasopressin].
    Kauli R; Laron Z
    Harefuah; 1975 Jul; 89(1):6-8. PubMed ID: 1158246
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin (DDAVP) in diabetes insipidus.
    Drug Ther Bull; 1976 Oct; 14(21):81-2. PubMed ID: 976094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.